These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
920 related items for PubMed ID: 18840009
1. Micafungin: a review of its use in adults for the treatment of invasive and oesophageal candidiasis, and as prophylaxis against Candida infections. Cross SA, Scott LJ. Drugs; 2008; 68(15):2225-55. PubMed ID: 18840009 [Abstract] [Full Text] [Related]
2. Micafungin: a review of its use in the prophylaxis and treatment of invasive Candida infections. Scott LJ. Drugs; 2012 Nov 12; 72(16):2141-65. PubMed ID: 23083111 [Abstract] [Full Text] [Related]
3. Micafungin: A Review in the Prophylaxis and Treatment of Invasive Candida Infections in Paediatric Patients. Scott LJ. Paediatr Drugs; 2017 Feb 12; 19(1):81-90. PubMed ID: 28083856 [Abstract] [Full Text] [Related]
4. Micafungin: a review of its use in the prophylaxis and treatment of invasive Candida infections in pediatric patients. Carter NJ, Keating GM. Paediatr Drugs; 2009 Feb 12; 11(4):271-91. PubMed ID: 19566111 [Abstract] [Full Text] [Related]
8. [Why might micafungin be the drug of choice in pediatric patients?]. Ramos Amador JT, Prieto Tato L, Guillén Martín S. Enferm Infecc Microbiol Clin; 2011 Mar 12; 29 Suppl 2():23-8. PubMed ID: 21420573 [Abstract] [Full Text] [Related]
9. [Micafungin for therapy of invasive candidiasis in solid organ transplant recipients]. Fortún-Abete J. Rev Iberoam Micol; 2009 Mar 31; 26(1):65-8. PubMed ID: 19463280 [Abstract] [Full Text] [Related]
12. Caspofungin: a review of its use in oesophageal candidiasis, invasive candidiasis and invasive aspergillosis. Keating G, Figgitt D. Drugs; 2003 Mar 31; 63(20):2235-63. PubMed ID: 14498760 [Abstract] [Full Text] [Related]
13. Echinocandins: the newest class of antifungals. Sucher AJ, Chahine EB, Balcer HE. Ann Pharmacother; 2009 Oct 31; 43(10):1647-57. PubMed ID: 19724014 [Abstract] [Full Text] [Related]
14. Pharmacology and metabolism of anidulafungin, caspofungin and micafungin in the treatment of invasive candidosis: review of the literature. Kofla G, Ruhnke M. Eur J Med Res; 2011 Apr 28; 16(4):159-66. PubMed ID: 21486730 [Abstract] [Full Text] [Related]
17. [Future role of micafungin in the treatment of invasive mycoses caused by filamentous fungi]. Salavert-Lletí M, Zaragoza-Crespo R. Rev Iberoam Micol; 2009 Mar 31; 26(1):81-9. PubMed ID: 19463284 [Abstract] [Full Text] [Related]
18. [Drug interactions in critically-ill patients. An important factor in the use of micafungin?]. Garnacho-Montero J, Jiménez Parrilla F. Enferm Infecc Microbiol Clin; 2011 Mar 31; 29 Suppl 2():33-7. PubMed ID: 21420575 [Abstract] [Full Text] [Related]
19. Efficacy of micafungin for the treatment of invasive candidiasis and candidaemia in patients with neutropenia. Chandrasekar P, Sirohi B, Seibel NL, Hsu JW, Azie N, Wu C, Ruhnke M. Mycoses; 2018 May 31; 61(5):331-336. PubMed ID: 29364548 [Abstract] [Full Text] [Related]
20. New developments and directions in the clinical application of the echinocandins. Chang CC, Slavin MA, Chen SC. Arch Toxicol; 2017 Apr 31; 91(4):1613-1621. PubMed ID: 28180946 [Abstract] [Full Text] [Related] Page: [Next] [New Search]